Shauna McGill

Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas

Anastasios Stathis, Sebastién J. Hotte, Eric X. Chen et al. · Clinical Cancer Research · 2011 · 100 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase II study of cediranib (AZD2171) in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: Final results of a PMH, Chicago and California consortia trial

Hal W. Hirte, Liat Vidal, Gini F. Fleming et al. · Journal of Clinical Oncology · 2008 · 83 citations

Medicine, Pharmacology, Pharmacotherapy +17

A phase 2 study of cediranib in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: A trial of the Princess Margaret, Chicago and California Phase II Consortia

Hal W. Hirte, Stéphanie Lheureux, Gini F. Fleming et al. · Gynecologic Oncology · 2015 · 75 citations

Medicine, Gynecology, Oncology +11

A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia

Jonathan How, Mark D. Minden, Brian Leber et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · 42 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase I Trial of Radiation With Concurrent and Consolidation Pemetrexed and Cisplatin in Patients With Unresectable Stage IIIA/B Non–Small-Cell Lung Cancer

Anthony Brade, Andrea Bezjak, Robert M. MacRae et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 35 citations

Medicine, Oncology, Radiation Oncology +11